Filling information for Frazier Life Sciences Management, L.P. as Treemap, investor disclosed 49 total holdings based on 2023-03-31 SEC fillings. A list of the exposed holdings
Product description
CUSIP | Symbol | Name | Title Of Class | Value in 1000's | Amount | |
---|---|---|---|---|---|---|
71722W107 | 71722W107 | Phathom Pharmaceuticals, Inc. | COM | 60027065 | 8407152 | |
483497103 | 483497103 | KALVISTA PHARMACEUTICALS INC | COM | 25457432 | 3238859 | |
28036F105 | 28036F105 | EDGEWISE THERAPEUTICS INC | COM | 4552015 | 682461 | |
925050106 | 925050106 | VERONA PHARMA PLC | SPONSORED ADS | 59122528 | 2944349 | |
869367102 | 869367102 | SUTRO BIOPHARMA INC | COM | 8207333 | 1776479 | |
22663K107 | 22663K107 | CRINETICS PHARMACEUTICALS IN | COM | 22722057 | 1414823 | |
92243G108 | 92243G108 | Vaxcyte, Inc. | COM | 52374739 | 1397405 | |
H9060V101 | H9060V101 | VECTIVBIO HLDG AG | ORD SHS | 11628911 | 1352199 | |
02083G100 | 02083G100 | ALPINE IMMUNE SCIENCES INC | COM | 23050044 | 2985757 | |
05280R100 | 05280R100 | AUTOLUS THERAPEUTICS PLC | SPON ADS | 6894217 | 3746857 | |
01671P100 | 01671P100 | ALLAKOS INC | COM | 4951444 | 1112684 | |
43157M102 | 43157M102 | HILLEVAX INC | COM | 161687732 | 9781472 | |
032724106 | 032724106 | ANAPTYSBIO INC | COM | 19577472 | 899700 | |
09609G100 | 09609G100 | BLUEBIRD BIO INC | COM | 4581607 | 1440757 | |
16961L106 | 16961L106 | CHINOOK THERAPEUTICS INC | COM | 100599691 | 4345559 | |
004225108 | 004225108 | ACADIA PHARMACEUTICALS INC | COM | 16135101 | 857338 | |
90240B106 | 90240B106 | TYRA BIOSCIENCES INC | COM | 22840452 | 1421310 | |
G72800108 | G72800108 | PROTHENA CORP PLC | SHS | 6199313 | 127900 | |
39868T105 | 39868T105 | GRITSTONE BIO INC | COM | 14351327 | 5162348 | |
87164F105 | 87164F105 | Syndax Pharmaceuticals, Inc. | COM | 78330659 | 3708838 | |
82686Q101 | 82686Q101 | SILENCE THERAPEUTICS PLC | ADS | 5463273 | 881173 | |
501147102 | 501147102 | KRYSTAL BIOTECH INC | COM | 75689284 | 945407 | |
29337E102 | 29337E102 | ENLIVEN THERAPEUTICS INC | COM | 18198528 | 830983 | |
76243J105 | 76243J105 | RHYTHM PHARMACEUTICALS INC | COM | 38618944 | 2164739 | |
76155X100 | 76155X100 | REVOLUTION MEDICINES INC | COM | 18508123 | 854484 | |
702712100 | 702712100 | Passage Bio, Inc. | COM | 3597997 | 3756915 | |
03969K108 | 03969K108 | Arcutis Biotherapeutics | COM | 95526552 | 8684232 | |
10806X102 | 10806X102 | BRIDGEBIO PHARMA INC | COM | 19425957 | 1171650 | |
N62509117 | N62509117 | NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | 920613 | 500333 | |
15678U128 | 15678U128 | CEREVEL THERAPEUTICS HLDNG I | COM | 9585270 | 393000 | |
05370A108 | 05370A108 | AVIDITY BIOSCIENCES INC | COM | 7675000 | 500000 | |
008064107 | 008064107 | AEROVATE THERAPEUTICS INC | COM | 6819679 | 338110 | |
89532M101 | 89532M101 | TREVI THERAPEUTICS INC | COM | 12327642 | 6663590 | |
19240Q201 | 19240Q201 | COGENT BIOSCIENCES INC | COM | 23297272 | 2159154 | |
H0036K147 | H0036K147 | ADC THERAPEUTICS SA | SHS | 3211709 | 1647030 | |
N62509109 | N62509109 | NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | 125550445 | 9341551 | |
556099109 | 556099109 | MACROGENICS INC | COM | 12211973 | 1703204 | |
98985Y108 | 98985Y108 | ZYMEWORKS INC | COM | 5514400 | 610000 | |
87650L103 | 87650L103 | Tarsus Pharmaceuticals, Inc. | COM | 22469214 | 1787527 | |
45258J102 | 45258J102 | Immunovant, Inc. | COM | 9085122 | 585759 | |
G63637139 | G63637139 | NABRIVA THERAPEUTICS PLC | SHS NEW 2022 | 29741 | 17025 | |
00461U105 | 00461U105 | ACLARIS THERAPEUTICS INC | COM | 2138810 | 264377 | |
04335A105 | 04335A105 | ARVINAS INC | COM | 7795243 | 285331 | |
88369M101 | 88369M101 | THESEUS PHARMACEUTICALS INC | COM | 19963963 | 2248194 | |
N5749R100 | N5749R100 | MERUS N V | COM | 13735214 | 746479 | |
76029N106 | 76029N106 | REPLIMUNE GROUP INC | COM | 12128217 | 686762 | |
604749101 | 604749101 | Mirum Pharmaceuticals, Inc. | COM | 92719770 | 3860107 | |
45826J105 | 45826J105 | INTELLIA THERAPEUTICS INC | COM | 7591303 | 203684 | |
61775R105 | 61775R105 | MORPHIC HLDG INC | COM | 8063994 | 214240 |